Importer of Controlled Substances Application: Lipomed, 21764-21768 [2021-08535]
Download as PDF
<![CDATA[
21764
Federal Register / Vol. 86, No. 77 / Friday, April 23, 2021 / Notices
that an industry in the United States is
materially injured by reason of imports
of seamless carbon and alloy steel
standard, line, and pressure pipe from
Czechia, provided for in subheadings
7304.19.10, 7304.19.50, 7304.31.60,
7304.39.00, 7304.51.50, 7304.59.60, and
7304.59.80 of the Harmonized Tariff
Schedule of the United States, that have
been found by the U.S. Department of
Commerce (‘‘Commerce’’) to be sold in
the United States at less than fair value
(‘‘LTFV’’).2
Background
The Commission instituted this
investigation effective July 8, 2020,
following receipt of petitions filed with
the Commission and Commerce by
Vallourec Star, LP, Houston, Texas. The
Commission scheduled the final phase
of the investigation following
notification of a preliminary
determination by Commerce that
imports of seamless carbon and alloy
steel standard, line, and pressure pipe
from Czechia were being sold at LTFV
within the meaning of section 733(b) of
the Act (19 U.S.C. 1673b(b)). Notice of
the scheduling of the final phase of the
Commission’s investigation and of a
public hearing to be held in connection
therewith was given by posting copies
of the notice in the Office of the
Secretary, U.S. International Trade
Commission, Washington, DC, and by
publishing the notice in the Federal
Register of December 31, 2021 (85 FR
86946). In light of the restrictions on
access to the Commission building due
to the COVID–19 pandemic, the
Commission conducted its hearing
through written testimony and video
conference on March 4, 2021. All
persons who requested the opportunity
were permitted to participate.
khammond on DSKJM1Z7X2PROD with NOTICES
The Commission made this
determination pursuant to § 735(b) of
the Act (19 U.S.C. 1673d(b)). It
completed and filed its determination in
this investigation on April 19, 2021. The
views of the Commission are contained
in USITC Publication 5183 (April 2021),
entitled Seamless Carbon and Alloy
Steel Standard, Line, and Pressure Pipe
from Czechia: Investigation No. 731–
TA–1529 (Final).
[FR Doc. 2021–08442 Filed 4–22–21; 8:45 am]
BILLING CODE 7020–02–P
FR 12909 (March 5, 2021).
VerDate Sep<11>2014
18:15 Apr 22, 2021
Drug Enforcement Administration
[Docket No. DEA–820]
Jkt 253001
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–08537 Filed 4–22–21; 8:45 am]
Importer of Controlled Substances
Application: Cardinal Health
BILLING CODE P
Drug Enforcement
Administration, Department of Justice.
ACTION: Notice of application.
DEPARTMENT OF JUSTICE
AGENCY:
Cardinal Health has applied
to be registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplemental Information
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 24, 2021. Such persons
may also file a written request for a
hearing on the application on or before
May 24, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on February 15, 2021
Cardinal Health, 15 Ingram Boulevard,
La Vergne, Tennessee 37086–3630,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
DATES:
Drug
code
Controlled substance
Nabilone .......................
By order of the Commission.
Issued: April 19, 2021.
Lisa Barton,
Secretary to the Commission.
2 86
DEPARTMENT OF JUSTICE
I
7379
Schedule
I II
The company plans to import finished
dosage unit products containing
Nabilone for distribution. No other
activity for this drug code is authorized
for this registration.
Approval of permit applications will
occur only when the registrant’s
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
[Docket No. DEA–821]
Importer of Controlled Substances
Application: Lipomed
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Lipomed has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplemental Information
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 24, 2021. Such persons
may also file a written request for a
hearing on the application on or before
May 24, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on February 26, 2021, 150
Cambridgepark Drive, Suite 705,
Cambridge, Massachusetts 02140,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
E:\FR\FM\23APN1.SGM
23APN1
21765
Federal Register / Vol. 86, No. 77 / Friday, April 23, 2021 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3-FMC) ..................................................................................................................................
Cathinone ............................................................................................................................................................................
Methcathinone .....................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) ..................................................................................................................................
Pentedrone (a-methylaminovalerophenone) .......................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ........................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ....................................................................................................................................
Naphyrone ...........................................................................................................................................................................
N-Ethylamphetamine ...........................................................................................................................................................
N,N-Dimethylamphetamine ..................................................................................................................................................
Fenethylline .........................................................................................................................................................................
Aminorex ..............................................................................................................................................................................
4-Methylaminorex (cis isomer) ............................................................................................................................................
Gamma Hydroxybutyric Acid ...............................................................................................................................................
Methaqualone ......................................................................................................................................................................
Mecloqualone ......................................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .......................................................................................................
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .....................................................
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .................
5-Fluoro-UR-144 and XLR11 ([1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone) ..................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..........................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ...........................................................................................................................
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...........................
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate)
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-)3-carboxamide ..............................................
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .....................................................................
5F-AB-PINACA (N-(1-amino-3methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ...........................
AB-CHMINACA (N-(1-amino-3-methyl-1--oxobutan-2-yl)-1-(cyclohexylmethyl)--1H-indazole-3-carboxamide) ..................
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) .............
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ...................................................
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ............
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................
Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido) 3,3-dimethylbutanoate) ...............................................................
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)
MMB-CHMICA , AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ............
N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboximide) ..................................................................................
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ................................................................
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ........................................
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .......................................................................................................
1-(5-Fluoropentyl)-1H-indazole-3-carboxamide ...................................................................................................................
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) .....................
4-CN-CUMYL-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboximide).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) .........................................................................
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..................................................................................
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..........................................................................................................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ....................................................................
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................................
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ...............................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...........................................................................................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ..........................................................................................................
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .............................................................
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ......................................................................................................
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ..................................................................................
4-methyl-alpha-ethylaminopentiophenone (4-MEAP) ..........................................................................................................
N-ethylhexedrone ................................................................................................................................................................
Alpha-ethyltryptamine ..........................................................................................................................................................
Ibogaine ...............................................................................................................................................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .....................................................................
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ...............................................
Lysergic acid diethylamide ..................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ....................................................................................................
Marihuana extract ................................................................................................................................................................
Marihuana ............................................................................................................................................................................
Tetrahydrocannabinols ........................................................................................................................................................
Parahexyl .............................................................................................................................................................................
Mescaline .............................................................................................................................................................................
2C-T-2, (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine) ................................................................................................
3,4,5-Trimethoxyamphetamine ............................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..............................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .................................................................................................................................
2,5-Dimethoxyamphetamine ................................................................................................................................................
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..........................................................................................................
VerDate Sep<11>2014
18:15 Apr 22, 2021
Jkt 253001
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
E:\FR\FM\23APN1.SGM
23APN1
Schedule
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
2572
6250
7008
7010
7011
7012
7019
7020
7021
7023
7024
7025
7031
7032
7033
7034
7035
7036
7042
7044
7047
7048
7049
7081
7083
7085
7089
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7104
7118
7122
7144
7173
7200
7201
7203
7221
7222
7225
7245
7246
7249
7260
7297
7298
7315
7348
7350
7360
7370
7374
7381
7385
7390
7391
7392
7395
7396
7398
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
21766
Federal Register / Vol. 86, No. 77 / Friday, April 23, 2021 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
2,5-Dimethoxy-4-ethylamphetamine ....................................................................................................................................
3,4-Methylenedioxyamphetamine ........................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ......................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ......................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...........................................................................................................................
3,4-Methylenedioxymethamphetamine ................................................................................................................................
4-Methoxyamphetamine ......................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .....................................................................................................................................
Alpha-methyltryptamine .......................................................................................................................................................
Bufotenine ............................................................................................................................................................................
Diethyltryptamine .................................................................................................................................................................
Dimethyltryptamine ..............................................................................................................................................................
Psilocybin .............................................................................................................................................................................
Psilocyn ...............................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .................................................................................................................................
4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-a-PVP) ................................................................................................
N-Ethyl-1-phenylcyclohexylamine ........................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ........................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ..................................................................................................................................
N-Ethyl-3-piperidyl benzilate ................................................................................................................................................
N-Methyl-3-piperidyl benzilate .............................................................................................................................................
N-Benzylpiperazine ..............................................................................................................................................................
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) .........................................................................................................
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ......................................................................................................
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ..........................................................................................................
2C-H (2-(2,5-Dimethoxyphenyl) ethanamine) .....................................................................................................................
2C-I (2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ............................................................................................................
2C-C (2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) .......................................................................................................
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) .........................................................................................................
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ..................................................................................................
2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) .........................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...........................................................................................................................
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .........................................................
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .........................................................
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ..............................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..........................................................................................................
Butylone ...............................................................................................................................................................................
Pentylone .............................................................................................................................................................................
N-Ethylpentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ........................................................
a-PHP, alpha-Pyrrolidinohexanophenone ...........................................................................................................................
a-PVP (alpha-pyrrolidinopentiophenone) ............................................................................................................................
a-PBP (alpha-pyrrolidinobutiophenone) ..............................................................................................................................
PV8, alpha-Pyrrolidinoheptaphenone ..................................................................................................................................
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ........................................................................................................
Norfentanyl ..........................................................................................................................................................................
Acetyldihydrocodeine ...........................................................................................................................................................
Benzylmorphine ...................................................................................................................................................................
Codeine-N-oxide ..................................................................................................................................................................
Cyprenorphine .....................................................................................................................................................................
Desomorphine .....................................................................................................................................................................
Etorphine (except HCl) ........................................................................................................................................................
Codeine methylbromide .......................................................................................................................................................
Dihydromorphine .................................................................................................................................................................
Difenoxin ..............................................................................................................................................................................
Heroin ..................................................................................................................................................................................
Hydromorphinol ...................................................................................................................................................................
Methyldesorphine ................................................................................................................................................................
Methyldihydromorphine .......................................................................................................................................................
Morphine methylbromide .....................................................................................................................................................
Morphine methylsulfonate ...................................................................................................................................................
Morphine-N-oxide ................................................................................................................................................................
Myrophine ............................................................................................................................................................................
Nicocodeine .........................................................................................................................................................................
Nicomorphine .......................................................................................................................................................................
Normorphine ........................................................................................................................................................................
Pholcodine ...........................................................................................................................................................................
Thebacon .............................................................................................................................................................................
Acetorphine ..........................................................................................................................................................................
Drotebanol ...........................................................................................................................................................................
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ...................................................................
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ......................................................................
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) .......................................................................................................
Acetylmethadol ....................................................................................................................................................................
VerDate Sep<11>2014
18:15 Apr 22, 2021
Jkt 253001
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
E:\FR\FM\23APN1.SGM
23APN1
7399
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7443
7455
7458
7470
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7543
7544
7545
7546
7548
7694
8366
9051
9052
9053
9054
9055
9056
9070
9145
9168
9200
9301
9302
9304
9305
9306
9307
9308
9309
9312
9313
9314
9315
9319
9335
9547
9551
9560
9601
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
21767
Federal Register / Vol. 86, No. 77 / Friday, April 23, 2021 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
Allylprodine ..........................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ..........................................................................................................
Alphameprodine ...................................................................................................................................................................
Alphamethadol .....................................................................................................................................................................
Benzethidine ........................................................................................................................................................................
Betacetylmethadol ...............................................................................................................................................................
Betameprodine ....................................................................................................................................................................
Betamethadol .......................................................................................................................................................................
Betaprodine .........................................................................................................................................................................
Clonitazene ..........................................................................................................................................................................
Dextromoramide ..................................................................................................................................................................
Diampromide .......................................................................................................................................................................
Diethylthiambutene ..............................................................................................................................................................
Dimenoxadol ........................................................................................................................................................................
Dimepheptanol .....................................................................................................................................................................
Dimethylthiambutene ...........................................................................................................................................................
Dioxaphetyl butyrate ............................................................................................................................................................
Dipipanone ...........................................................................................................................................................................
Ethylmethylthiambutene ......................................................................................................................................................
Etonitazene ..........................................................................................................................................................................
Etoxeridine ...........................................................................................................................................................................
Furethidine ...........................................................................................................................................................................
Hydroxypethidine .................................................................................................................................................................
Ketobemidone ......................................................................................................................................................................
Levomoramide .....................................................................................................................................................................
Levophenacylmorphan ........................................................................................................................................................
Morpheridine ........................................................................................................................................................................
Noracymethadol ...................................................................................................................................................................
Norlevorphanol ....................................................................................................................................................................
Normethadone .....................................................................................................................................................................
Norpipanone ........................................................................................................................................................................
Phenadoxone .......................................................................................................................................................................
Phenampromide ..................................................................................................................................................................
Phenoperidine ......................................................................................................................................................................
Piritramide ............................................................................................................................................................................
Proheptazine ........................................................................................................................................................................
Properidine ..........................................................................................................................................................................
Racemoramide ....................................................................................................................................................................
Trimeperidine .......................................................................................................................................................................
Phenomorphan ....................................................................................................................................................................
Propiram ..............................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ..........................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ..................................................................................................................
Tilidine .................................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .....................................................................................
Para-Fluorofentanyl .............................................................................................................................................................
3-Methylfentanyl ..................................................................................................................................................................
Alpha-Methylfentanyl ...........................................................................................................................................................
Acetyl-alpha-methylfentanyl .................................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ...........................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...................................................................................
Butyryl Fentanyl ...................................................................................................................................................................
Para-fluorobutyryl fentanyl ...................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .............................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .............................................................................................
Para-chloroisobutyryl fentanyl .............................................................................................................................................
Isobutyryl fentanyl ................................................................................................................................................................
Beta-hydroxyfentanyl ...........................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ............................................................................................................................................
Alpha-methylthiofentanyl .....................................................................................................................................................
3-Methylthiofentanyl .............................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .................................................................
Thiofentanyl .........................................................................................................................................................................
Beta-hydroxythiofentanyl .....................................................................................................................................................
Para-methoxybutyryl fentanyl ..............................................................................................................................................
Ocfentanil .............................................................................................................................................................................
Valeryl fentanyl ....................................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) .............................................................................
Cyclopropyl Fentanyl ...........................................................................................................................................................
Cyclopentyl fentanyl ............................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .........................................................................................
Amphetamine .......................................................................................................................................................................
Methamphetamine ...............................................................................................................................................................
Lisdexamfetamine ................................................................................................................................................................
VerDate Sep<11>2014
18:15 Apr 22, 2021
Jkt 253001
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
E:\FR\FM\23APN1.SGM
23APN1
9602
9603
9604
9605
9606
9607
9608
9609
9611
9612
9613
9615
9616
9617
9618
9619
9621
9622
9623
9624
9625
9626
9627
9628
9629
9631
9632
9633
9634
9635
9636
9637
9638
9641
9642
9643
9644
9645
9646
9647
9649
9661
9663
9750
9811
9812
9813
9814
9815
9816
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9840
9843
9845
9847
9850
1100
1105
1205
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
21768
Federal Register / Vol. 86, No. 77 / Friday, April 23, 2021 / Notices
Controlled substance
Drug code
khammond on DSKJM1Z7X2PROD with NOTICES
Phenmetrazine .....................................................................................................................................................................
Methylphenidate ..................................................................................................................................................................
Amobarbital ..........................................................................................................................................................................
Pentobarbital ........................................................................................................................................................................
Secobarbital .........................................................................................................................................................................
Glutethimide .........................................................................................................................................................................
Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration
(FDA).
Nabilone ...............................................................................................................................................................................
1-Phenylcyclohexylamine ....................................................................................................................................................
Phencyclidine .......................................................................................................................................................................
ANPP (4-Anilino-N-phenethyl-4-piperidine) .........................................................................................................................
Phenylacetone .....................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ....................................................................................................................................
Alphaprodine ........................................................................................................................................................................
Anileridine ............................................................................................................................................................................
Cocaine ................................................................................................................................................................................
Codeine ...............................................................................................................................................................................
Etorphine HCl ......................................................................................................................................................................
Dihydrocodeine ....................................................................................................................................................................
Oxycodone ...........................................................................................................................................................................
Hydromorphone ...................................................................................................................................................................
Diphenoxylate ......................................................................................................................................................................
Ecgonine ..............................................................................................................................................................................
Ethylmorphine ......................................................................................................................................................................
Hydrocodone .......................................................................................................................................................................
Levomethorphan ..................................................................................................................................................................
Levorphanol .........................................................................................................................................................................
Isomethadone ......................................................................................................................................................................
Meperidine ...........................................................................................................................................................................
Meperidine-intermediate-A ..................................................................................................................................................
Meperidine intermediate-B ..................................................................................................................................................
Meperidine intermediate-C ..................................................................................................................................................
Metazocine ..........................................................................................................................................................................
Methadone ...........................................................................................................................................................................
Methadone intermediate ......................................................................................................................................................
Metopon ...............................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..................................................................................................................
Morphine ..............................................................................................................................................................................
Oripavine .............................................................................................................................................................................
Thebaine ..............................................................................................................................................................................
Dihydroetorphine .................................................................................................................................................................
Levo-alphacetylmethadol .....................................................................................................................................................
Oxymorphone ......................................................................................................................................................................
Noroxymorphone .................................................................................................................................................................
Phenazocine ........................................................................................................................................................................
Thiafentanil ..........................................................................................................................................................................
Piminodine ...........................................................................................................................................................................
Racemethorphan .................................................................................................................................................................
Racemorphan ......................................................................................................................................................................
Alfentanil ..............................................................................................................................................................................
Remifentanil .........................................................................................................................................................................
Sufentanil .............................................................................................................................................................................
Carfentanil ...........................................................................................................................................................................
Tapentadol ...........................................................................................................................................................................
Bezitramide ..........................................................................................................................................................................
Fentanyl ...............................................................................................................................................................................
Moramide-intermediate ........................................................................................................................................................
The company plans to import
analytical reference standards for
distribution to its customers for research
and analytics purposes. Placement of
these drug codes onto the company’s
registration does not translate into
automatic approval of subsequent
permit applications to import controlled
substances. Approval of permit
applications will occur only when the
registrant’s business activity is
VerDate Sep<11>2014
18:15 Apr 22, 2021
Jkt 253001
Schedule
1631
1724
2125
2270
2315
2550
7365
II
II
II
II
II
II
II
7379
7460
7471
8333
8501
8603
9010
9020
9041
9050
9059
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9240
9250
9254
9260
9273
9300
9330
9333
9334
9648
9652
9668
9715
9729
9730
9732
9733
9737
9739
9740
9743
9780
9800
9801
9802
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
consistent with what is authorized in 21
U.S.C. 952(a)(2). Authorization will not
extend to the import of FDA-approved
or non-approved finished dosage forms
for commercial sale.
DEPARTMENT OF JUSTICE
William T. McDermott,
Assistant Administrator.
Bulk Manufacturer of Controlled
Substances Application: Rhodes
Technologies
[FR Doc. 2021–08535 Filed 4–22–21; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00086
Fmt 4703
Drug Enforcement Administration
[Docket No. DEA–825]
Drug Enforcement
Administration, Justice.
AGENCY:
Sfmt 4703
E:\FR\FM\23APN1.SGM
23APN1
]]>Agencies
[Federal Register Volume 86, Number 77 (Friday, April 23, 2021)]
[Notices]
[Pages 21764-21768]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08535]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-821]
Importer of Controlled Substances Application: Lipomed
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Lipomed has applied to be registered as an importer of basic
class(es) of controlled substance(s). Refer to Supplemental Information
listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before May 24, 2021.
Such persons may also file a written request for a hearing on the
application on or before May 24, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 26, 2021, 150 Cambridgepark Drive, Suite
705, Cambridge, Massachusetts 02140, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
[[Page 21765]]
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)... 1233 I
Cathinone............................ 1235 I
Methcathinone........................ 1237 I
4-Fluoro-N-methylcathinone (4-FMC)... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC).... 1249 I
Naphyrone............................ 1258 I
N-Ethylamphetamine................... 1475 I
N,N-Dimethylamphetamine.............. 1480 I
Fenethylline......................... 1503 I
Aminorex............................. 1585 I
4-Methylaminorex (cis isomer)........ 1590 I
Gamma Hydroxybutyric Acid............ 2010 I
Methaqualone......................... 2565 I
Mecloqualone......................... 2572 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl- 7010 I
1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 ([1-(5- 7011 I
Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone).
AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide).
JWH-019 (1-Hexyl-3-(1- 7019 I
naphthoyl)indole).
MDMB-FUBINACA (Methyl 2-(1-(4- 7020 I
fluorobenzyl)-1H-indazole-3-
carboxamido)-3,3-dimethylbutanoate).
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA 7021 I
(2-(1-(4-fluorobenzyl)-1Hindazole-3-
carboxamido)-3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1- 7023 I
oxobutan-2-yl)-1-pentyl-1H-indazole-
)3-carboxamide.
THJ-2201 ([1-(5-fluoropentyl)-1H- 7024 I
indazol-3-yl](naphthalen-1-
yl)methanone).
5F-AB-PINACA (N-(1-amino-3methyl-1- 7025 I
oxobutan-2-yl)-1-(5-fluoropentyl)-1H-
indazole-3-carboxamide).
AB-CHMINACA (N-(1-amino-3-methyl-1-- 7031 I
oxobutan-2-yl)-1-(cyclohexylmethyl)--
1H-indazole-3-carboxamide).
MAB-CHMINACA (N-(1-amino-3,3dimethyl- 7032 I
1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)- 7033 I
1H-indazole-3-carboxamido)-3-
methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1- 7034 I
(5-fluoropentyl)-1H-indazole-3-
carboxamido)-3,3-dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-
3-carboxamide).
Ethyl 2-(1-(5-fluoropentyl)-1H- 7036 I
indazole-3-carboxamido) 3,3-
dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2- 7042 I
(1-(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate).
MMB-CHMICA , AMB-CHMICA (methyl 2-(1- 7044 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3-methylbutanoate).
N-(Adamantan-1-yl)-1-(4-fluorobenzyl)- 7047 I
1H-indazole-3-carboximide).
APINACA and AKB48 (N-(1-Adamantyl)-1- 7048 I
pentyl-1H-indazole-3-carboxamide).
5F-APINACA, 5F-AKB48 (N-(adamantan-1- 7049 I
yl)-1-(5-fluoropentyl)-1H-indazole-3-
carboxamide).
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
1-(5-Fluoropentyl)-1H-indazole-3- 7083 I
carboxamide.
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N- 7085 I
(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-
b]pyridine-3-carboxamide).
4-CN-CUMYL-BUTINACA, 4-cyano-CUMYL- 7089 I
BUTINACA, 4-CN-CUMYL BINACA, CUMYL-
4CN-BINACA, SGT-78 (1-(4-cyanobutyl)-
N-(2-phenylpropan-2-yl)-1H-indazole-
3-carboximide).
SR-19 (Also known as RCS-4) (1-Pentyl- 7104 I
3-[(4-methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3- 7144 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone).
JWH-073 (1-Butyl-3-(1- 7173 I
naphthoyl)indole).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3- 7200 I
(1-naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5- 7221 I
fluoropentyl)-1H-indole-3-
carboxylate).
PB-22 (Quinolin-8-yl 1-pentyl-1H- 7222 I
indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-
carboxylate).
4-methyl-alpha- 7245 I
ethylaminopentiophenone (4-MEAP).
N-ethylhexedrone..................... 7246 I
Alpha-ethyltryptamine................ 7249 I
Ibogaine............................. 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide........... 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-7).
Marihuana extract.................... 7350 I
Marihuana............................ 7360 I
Tetrahydrocannabinols................ 7370 I
Parahexyl............................ 7374 I
Mescaline............................ 7381 I
2C-T-2, (2-(4-Ethylthio-2,5- 7385 I
dimethoxyphenyl) ethanamine).
3,4,5-Trimethoxyamphetamine.......... 7390 I
4-Bromo-2,5-dimethoxyamphetamine..... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine.. 7392 I
4-Methyl-2,5-dimethoxyamphetamine.... 7395 I
2,5-Dimethoxyamphetamine............. 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
[[Page 21766]]
2,5-Dimethoxy-4-ethylamphetamine..... 7399 I
3,4-Methylenedioxyamphetamine........ 7400 I
5-Methoxy-3,4- 7401 I
methylenedioxyamphetamine.
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N-ethylamphetamine 7404 I
3,4-Methylenedioxymethamphetamine.... 7405 I
4-Methoxyamphetamine................. 7411 I
5-Methoxy-N-N-dimethyltryptamine..... 7431 I
Alpha-methyltryptamine............... 7432 I
Bufotenine........................... 7433 I
Diethyltryptamine.................... 7434 I
Dimethyltryptamine................... 7435 I
Psilocybin........................... 7437 I
Psilocyn............................. 7438 I
5-Methoxy-N,N-diisopropyltryptamine.. 7439 I
4-chloro-alpha- 7443 I
pyrrolidinovalerophenone (4-chloro-a-
PVP).
N-Ethyl-1-phenylcyclohexylamine...... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine.... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine 7470 I
1-[1-(2- 7473 I
Thienyl)cyclohexyl]pyrrolidine.
N-Ethyl-3-piperidyl benzilate........ 7482 I
N-Methyl-3-piperidyl benzilate....... 7484 I
N-Benzylpiperazine................... 7493 I
4-MePPP (4-Methyl- 7498 I
alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4- 7508 I
methylphenyl) ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine).
2C-H (2-(2,5-Dimethoxyphenyl) 7517 I
ethanamine).
2C-I (2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine).
2C-C (2-(4-Chloro-2,5- 7519 I
dimethoxyphenyl) ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro- 7521 I
phenyl) ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)- 7524 I
propylphenyl) ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone) 7535 I
25B-NBOMe (2-(4-bromo-2,5- 7536 I
dimethoxyphenyl)-N-(2-methoxybenzyl)
ethanamine).
25C-NBOMe (2-(4-chloro-2,5- 7537 I
dimethoxyphenyl)-N-(2-methoxybenzyl)
ethanamine).
25I-NBOMe (2-(4-iodo-2,5- 7538 I
dimethoxyphenyl)-N-(2-methoxybenzyl)
ethanamine).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone............................. 7541 I
Pentylone............................ 7542 I
N-Ethylpentylone, ephylone (1-(1,3- 7543 I
benzodioxol-5-yl)-2-(ethylamino)-
pentan-1-one).
[alpha]-PHP, alpha- 7544 I
Pyrrolidinohexanophenone.
[alpha]-PVP (alpha- 7545 I
pyrrolidinopentiophenone).
[alpha]-PBP (alpha- 7546 I
pyrrolidinobutiophenone).
PV8, alpha-Pyrrolidinoheptaphenone... 7548 I
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
Norfentanyl.......................... 8366 I
Acetyldihydrocodeine................. 9051 I
Benzylmorphine....................... 9052 I
Codeine-N-oxide...................... 9053 I
Cyprenorphine........................ 9054 I
Desomorphine......................... 9055 I
Etorphine (except HCl)............... 9056 I
Codeine methylbromide................ 9070 I
Dihydromorphine...................... 9145 I
Difenoxin............................ 9168 I
Heroin............................... 9200 I
Hydromorphinol....................... 9301 I
Methyldesorphine..................... 9302 I
Methyldihydromorphine................ 9304 I
Morphine methylbromide............... 9305 I
Morphine methylsulfonate............. 9306 I
Morphine-N-oxide..................... 9307 I
Myrophine............................ 9308 I
Nicocodeine.......................... 9309 I
Nicomorphine......................... 9312 I
Normorphine.......................... 9313 I
Pholcodine........................... 9314 I
Thebacon............................. 9315 I
Acetorphine.......................... 9319 I
Drotebanol........................... 9335 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benza
mide)).
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
Acetylmethadol....................... 9601 I
[[Page 21767]]
Allylprodine......................... 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine....................... 9604 I
Alphamethadol........................ 9605 I
Benzethidine......................... 9606 I
Betacetylmethadol.................... 9607 I
Betameprodine........................ 9608 I
Betamethadol......................... 9609 I
Betaprodine.......................... 9611 I
Clonitazene.......................... 9612 I
Dextromoramide....................... 9613 I
Diampromide.......................... 9615 I
Diethylthiambutene................... 9616 I
Dimenoxadol.......................... 9617 I
Dimepheptanol........................ 9618 I
Dimethylthiambutene.................. 9619 I
Dioxaphetyl butyrate................. 9621 I
Dipipanone........................... 9622 I
Ethylmethylthiambutene............... 9623 I
Etonitazene.......................... 9624 I
Etoxeridine.......................... 9625 I
Furethidine.......................... 9626 I
Hydroxypethidine..................... 9627 I
Ketobemidone......................... 9628 I
Levomoramide......................... 9629 I
Levophenacylmorphan.................. 9631 I
Morpheridine......................... 9632 I
Noracymethadol....................... 9633 I
Norlevorphanol....................... 9634 I
Normethadone......................... 9635 I
Norpipanone.......................... 9636 I
Phenadoxone.......................... 9637 I
Phenampromide........................ 9638 I
Phenoperidine........................ 9641 I
Piritramide.......................... 9642 I
Proheptazine......................... 9643 I
Properidine.......................... 9644 I
Racemoramide......................... 9645 I
Trimeperidine........................ 9646 I
Phenomorphan......................... 9647 I
Propiram............................. 9649 I
1-Methyl-4-phenyl-4- 9661 I
propionoxypiperidine.
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Tilidine............................. 9750 I
Acryl fentanyl (N-(1- 9811 I
phenethylpiperidin-4-yl)-N-
phenylacrylamide).
Para-Fluorofentanyl.................. 9812 I
3-Methylfentanyl..................... 9813 I
Alpha-Methylfentanyl................. 9814 I
Acetyl-alpha-methylfentanyl.......... 9815 I
N-(2-fluorophenyl)-N-(1- 9816 I
phenethylpiperidin-4-yl)propionamide.
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Butyryl Fentanyl..................... 9822 I
Para-fluorobutyryl fentanyl.......... 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-
phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4- 9825 I
yl)-N-phenylacetamide.
Para-chloroisobutyryl fentanyl....... 9826 I
Isobutyryl fentanyl.................. 9827 I
Beta-hydroxyfentanyl................. 9830 I
Beta-hydroxy-3-methylfentanyl........ 9831 I
Alpha-methylthiofentanyl............. 9832 I
3-Methylthiofentanyl................. 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).
Thiofentanyl......................... 9835 I
Beta-hydroxythiofentanyl............. 9836 I
Para-methoxybutyryl fentanyl......... 9837 I
Ocfentanil........................... 9838 I
Valeryl fentanyl..................... 9840 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide).
Cyclopropyl Fentanyl................. 9845 I
Cyclopentyl fentanyl................. 9847 I
Fentanyl related-compounds as defined 9850 I
in 21 CFR 1308.11(h).
Amphetamine.......................... 1100 II
Methamphetamine...................... 1105 II
Lisdexamfetamine..................... 1205 II
[[Page 21768]]
Phenmetrazine........................ 1631 II
Methylphenidate...................... 1724 II
Amobarbital.......................... 2125 II
Pentobarbital........................ 2270 II
Secobarbital......................... 2315 II
Glutethimide......................... 2550 II
Dronabinol in an oral solution in a 7365 II
drug product approved for marketing
by the U.S. Food and Drug
Administration (FDA).
Nabilone............................. 7379 II
1-Phenylcyclohexylamine.............. 7460 II
Phencyclidine........................ 7471 II
ANPP (4-Anilino-N-phenethyl-4- 8333 II
piperidine).
Phenylacetone........................ 8501 II
1-Piperidinocyclohexanecarbonitrile.. 8603 II
Alphaprodine......................... 9010 II
Anileridine.......................... 9020 II
Cocaine.............................. 9041 II
Codeine.............................. 9050 II
Etorphine HCl........................ 9059 II
Dihydrocodeine....................... 9120 II
Oxycodone............................ 9143 II
Hydromorphone........................ 9150 II
Diphenoxylate........................ 9170 II
Ecgonine............................. 9180 II
Ethylmorphine........................ 9190 II
Hydrocodone.......................... 9193 II
Levomethorphan....................... 9210 II
Levorphanol.......................... 9220 II
Isomethadone......................... 9226 II
Meperidine........................... 9230 II
Meperidine-intermediate-A............ 9232 II
Meperidine intermediate-B............ 9233 II
Meperidine intermediate-C............ 9234 II
Metazocine........................... 9240 II
Methadone............................ 9250 II
Methadone intermediate............... 9254 II
Metopon.............................. 9260 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine............................. 9300 II
Oripavine............................ 9330 II
Thebaine............................. 9333 II
Dihydroetorphine..................... 9334 II
Levo-alphacetylmethadol.............. 9648 II
Oxymorphone.......................... 9652 II
Noroxymorphone....................... 9668 II
Phenazocine.......................... 9715 II
Thiafentanil......................... 9729 II
Piminodine........................... 9730 II
Racemethorphan....................... 9732 II
Racemorphan.......................... 9733 II
Alfentanil........................... 9737 II
Remifentanil......................... 9739 II
Sufentanil........................... 9740 II
Carfentanil.......................... 9743 II
Tapentadol........................... 9780 II
Bezitramide.......................... 9800 II
Fentanyl............................. 9801 II
Moramide-intermediate................ 9802 II
------------------------------------------------------------------------
The company plans to import analytical reference standards for
distribution to its customers for research and analytics purposes.
Placement of these drug codes onto the company's registration does not
translate into automatic approval of subsequent permit applications to
import controlled substances. Approval of permit applications will
occur only when the registrant's business activity is consistent with
what is authorized in 21 U.S.C. 952(a)(2). Authorization will not
extend to the import of FDA-approved or non-approved finished dosage
forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-08535 Filed 4-22-21; 8:45 am]
BILLING CODE 4410-09-P
